AR115865A2 - THERAPEUTIC COMPOUNDS - Google Patents
THERAPEUTIC COMPOUNDSInfo
- Publication number
- AR115865A2 AR115865A2 ARP190102131A ARP190102131A AR115865A2 AR 115865 A2 AR115865 A2 AR 115865A2 AR P190102131 A ARP190102131 A AR P190102131A AR P190102131 A ARP190102131 A AR P190102131A AR 115865 A2 AR115865 A2 AR 115865A2
- Authority
- AR
- Argentina
- Prior art keywords
- therapeutic compounds
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Reivindicación 1: Un compuesto de formula (1), o una sal farmacéuticamente aceptable del mismo.Claim 1: A compound of formula (1), or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662377312P | 2016-08-19 | 2016-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR115865A2 true AR115865A2 (en) | 2021-03-03 |
Family
ID=64499920
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102299A AR109364A1 (en) | 2016-08-19 | 2017-08-17 | ANTIVIRAL COMPOUNDS |
| ARP190102131A AR115865A2 (en) | 2016-08-19 | 2019-07-29 | THERAPEUTIC COMPOUNDS |
| ARP190103689A AR117709A2 (en) | 2016-08-19 | 2019-12-16 | PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTITUTED 1H-INDAZOLE COMPOUND, SAID COMPOUND AND PARENTERAL FORMULATION OF THE SAME |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102299A AR109364A1 (en) | 2016-08-19 | 2017-08-17 | ANTIVIRAL COMPOUNDS |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190103689A AR117709A2 (en) | 2016-08-19 | 2019-12-16 | PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTITUTED 1H-INDAZOLE COMPOUND, SAID COMPOUND AND PARENTERAL FORMULATION OF THE SAME |
Country Status (2)
| Country | Link |
|---|---|
| AR (3) | AR109364A1 (en) |
| HR (1) | HRP20191601T1 (en) |
-
2017
- 2017-08-17 AR ARP170102299A patent/AR109364A1/en not_active Application Discontinuation
- 2017-08-17 HR HRP20191601 patent/HRP20191601T1/en unknown
-
2019
- 2019-07-29 AR ARP190102131A patent/AR115865A2/en not_active Application Discontinuation
- 2019-12-16 AR ARP190103689A patent/AR117709A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20191601T1 (en) | 2019-11-29 |
| AR109364A1 (en) | 2018-11-21 |
| AR117709A2 (en) | 2021-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2020014586A2 (en) | Compounds | |
| DOP2020000102A (en) | HELPFUL COMPOUNDS TO INHIBIT CDK7 | |
| CO2019005165A2 (en) | Pyridone compound as c-met inhibitor | |
| MX388748B (en) | TREATMENT METHODS USING A JAK INHIBITOR COMPOUND. | |
| AR108711A1 (en) | FXR MODULATING COMPOUNDS (NR1H4) | |
| NI201700020A (en) | AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS | |
| MX380394B (en) | NOVEL BIPHENYL COMPOUND OR A SALT THEREOF. | |
| PE20151542A1 (en) | TETRAHYDROPYRROTHIAZINE COMPOUNDS | |
| AR101995A1 (en) | INTEGRINA AVB6 ANTAGONIST COMPOUNDS | |
| EA201791420A1 (en) | TRIAZOLOPYRIMIDIN COMPOUNDS AND THEIR APPLICATIONS | |
| AR103680A1 (en) | BACE1 SELECTIVE INHIBITORS | |
| AR117920A1 (en) | HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS | |
| AR105821A1 (en) | USEFUL COMPOUNDS TO INHIBIT ROR-g-T | |
| AR095097A1 (en) | PHENOXYETOXI COMPOUNDS | |
| SV2016005313A (en) | CARBOXAMIDE DERIVATIVES | |
| CO2018001383A2 (en) | Derivatives of n- [pyridin-4-yl] methyl] -4 - {(1r) -1 - [(3s) -3-methyl-2,5-dioxopyrrolidin-3-yl] ethyl} benzamide as antagonists of the cgrp receptor " | |
| MX2019002369A (en) | COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH A MITOCHONDRIAL DYSFUNCTION. | |
| EA201990313A1 (en) | DERIVATIVE TRIAZOLOPYRAZINONE USED AS A HUMAN PDE1 INHIBITOR | |
| MX2017006110A (en) | Quinoline carboxamides for use in the treatment of leukemia. | |
| EA202091169A1 (en) | SMAC MIMETICS USED AS IAP INHIBITORS AND THEIR APPLICATION | |
| ECSP18038014A (en) | SODIUM CHANNEL BLOCKER | |
| AR110770A1 (en) | POTASSIUM CHANNEL MODULATORS | |
| CO2019013254A2 (en) | 5,6-fused bicyclic compounds and compositions for the treatment of parasitic diseases | |
| MX2021009261A (en) | Fluorovinylbenzamide compound as pd-l1 immunomodulator. | |
| PH12021550452A1 (en) | Methods of treating mycobacterial infections using tetracycline compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |